Voluntary SARS CoV 2 testing of the hemodialysis population may require incentives beyond varying test frequency. Only 8% of patients voluntarily comply with repeat SARS-CoV-2 testing in hemodialysis ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...
The SARS-CoV-2 pandemic has prompted extensive developments in diagnostic testing and population surveillance, which are critical tools in mitigating viral spread. Strategies have evolved from ...
CARLSBAD, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results